Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Guy Hermans, Ph.D. Chief Scientific Officer at Isogenica

Profile

Guy joined Isogenica as CSO in 2016. He brings in over a decade of experience in antibody fragment discovery and early development, as well as antibody discovery technology development. At Isogenica, he leads the internal technology and product development, as well as drive scientific interactions with licensees and other partners.

In his previous position as Research Fellow at Ablynx, he conceived of many of its internal drug development programs and led a number of them through preclinical development. He was also responsible for several technology development programs, addressing challenging target classes or enabling novel applications for domain antibodies.

During his academic training, Guy did research in the pathogenesis and immunotherapy of autoimmune and inflammatory disorders, ranging from cell-based immunotherapy clinical trials in Multiple Sclerosis patients (PhD, University of Hasselt) to preclinical in vitro/in vivo target discovery and validation work as postdoc at Stanford University Medical School.



Agenda Sessions